• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Myasthenia Gravis

Latest News

Myasthenia gravis | Image Credit: © lhphotos-stock.adobe.com
EU Approves Self-Administered Rozanolixizumab for Myasthenia Gravis

February 24th 2025

With 2 new self-administration methods, patients living with generalized myasthenia gravis can be more empowered to manage their treatment with greater independence and control.

AChR-Ab titers and the AChR-Ab rates of change correlated with myasthenia gravis disease severity scores in a recent study. | Image credit: luchschenF - stock.adobe.com
AChR-Ab Titers Associated With Myasthenia Gravis Severity

February 21st 2025

Anesthia care | Image Credit: ©Nadezhda Buravleva-stock.adobe.com
Sugammadex Safe, Effective Post Surgery in Myasthenia Gravis

February 18th 2025

Test for myasthenia gravis | Image Credit: © luchschenF-stock.adobe.com
Exacerbations Drive Costs, Utilization in Myasthenia Gravis

January 24th 2025

Eculizumab | Image Credit: © molekuul.be - stock.adobe.com
Eculizumab Shows Promise in Thymoma-Associated Myasthenia Gravis

January 14th 2025

More News

© 2025 MJH Life Sciences
AJMC®
All rights reserved.